ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study

Qin, Shukui; Chen, Zhendong; Fang, Weijia; Ren, Zhenggang; Xu, Ruocai; Ryoo, Baek-Yeol; Meng, Zhiqiang; Bai, Yuxian; Chen, Xiaoming; Liu, Xiufeng; Xiao, Juxiang; Ho, Gwo Fuang; Mao, Yimin; Ye, Xing; Ying, Jieer; Li, Jianfeng; Zhong, Wen Yan; Zhou, Yu; Siegel, Abby B.; Hao, Chunyi复旦大学; 广东省人民医院; 安徽医科大学; 上海交通大学; 哈尔滨医科大学; 浙江大学; 西安交通大学; 中国医科大学; 中国科学院研究生院; 中国科学院; 1
ASCO Gastrointestinal Cancers Symposium2022-2-1DOI: 10.1200/JCO.2022.40.4_suppl.383
73被引20阅读
引用收藏
分享
相关
加载中…
  • Landmark analysis of OS by response status in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the KEYNOTE-394 study
    Ren, Zhenggang; Chen, Zhendong; Fang, Weijia; Ou, Shuangyan; Ryoo, Baek-Yeol; Meng, Zhiqiang; Bai, Yuxian; Chen, Xiaoming; Liu, Xiufeng; Xiao, Juxiang; Ho, Gwo Fuang; Mao, Yimin; Wang, Xin; Jieer, Ying; Hao, Chunyi; Shen, Hujia; Lin, Jianxin; Hatogai, Ken; Siegel, Abby B.; Qin, ShukuiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
  • Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)
    Chen, Jinzhang; Zang, Mengya; Pang, Huajin; Li, Chuanjiang; Zhao, Jianbo; Guo, Yabing; Hou, JinlinAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 1
  • Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)
    Zang, M.; Li, Q.; Pang, H.; Hu, X.; Li, R.; Yuan, G.; Li, W.; Guo, Y.; Chen, J.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
查看全部 →

会议信息

会议名称
ASCO Gastrointestinal Cancers Symposium
会议日期
2022-01-20 至 2022-01-22
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2022-02-01
DOI
10.1200/JCO.2022.40.4_suppl.383
资助标注
Merck Sharp Dohme Corp.
收录
ISTP · SCIE

作者

  • Q

    Qin, Shukui (第一作者)

  • C

    Chen, Zhendong

查看全部 20 位作者收起作者
  • F

    Fang, Weijia

  • R

    Ren, Zhenggang

  • X

    Xu, Ruocai

  • R

    Ryoo, Baek-Yeol

  • M

    Meng, Zhiqiang

  • B

    Bai, Yuxian

  • C

    Chen, Xiaoming

  • L

    Liu, Xiufeng

  • X

    Xiao, Juxiang

  • H

    Ho, Gwo Fuang

  • M

    Mao, Yimin

  • Y

    Ye, Xing

  • Y

    Ying, Jieer

  • L

    Li, Jianfeng

  • Z

    Zhong, Wen Yan

  • Z

    Zhou, Yu

  • S

    Siegel, Abby B.

  • H

    Hao, Chunyi

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417